Disc Medicine, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of treatments for hematologic diseases. It assembles a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. The company was founded in October 2017 and is headquartered in Watertown, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
155
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Disc Medicine Inc market cap is $3.42B.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Disc Medicine Inc 52 week high is $99.50 as of November 21, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Disc Medicine Inc 52 week low is $40.00 as of November 21, 2026.
Disc Medicine Inc stock price today is $75.14.
Disc Medicine Inc stock price yesterday was $76.11.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Disc Medicine Inc's P/E ratio is -11.86.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Disc Medicine Inc P/B ratio is 4.8024.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Disc Medicine Inc 50-day moving average is $71.71.